Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kozo Morimoto

Showing results (151-160 of 191) with videos related to

Pageof 20
Sort By:
Respiratory Medicine|September 12, 2020
Clinical significance of anti-glycopeptidolipid-core IgA antibodies in patients newly diagnosed with Mycobacterium avium complex lung diseaseShuichi Matsuda, Takanori Asakura, Kozo Morimoto, et al.
Expert Review of Respiratory Medicine|March 4, 2022
Decreased incremental shuttle walk test distance characterized by fibrocavitary lesions in non-tuberculous mycobacterial pulmonary diseaseKazuki Ono, Mitsuru Tabusadani, Kazumasa Yamane, et al.
Orphanet Journal of Rare Diseases|October 15, 2025
Genetic investigation of sinopulmonary diseases in Vietnam: seeking specific causes from non-specific symptomsPhan Thu Phuong, Nguyen Thi Le Hang, Minako Hijikata, et al.
Respiratory Medicine|May 27, 2019
Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in JapanKoji Furuuchi, Kozo Morimoto, Takashi Yoshiyama, et al.
Respiratory Investigation|January 10, 2026
Efficacy and safety of brensocatib in Japanese patients with non-cystic fibrosis bronchiectasis: Analysis of the ASPEN trialKozo Morimoto, James D Chalmers, Pierre-Régis Burgel, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 3, 2020
Clinical risk factors related to treatment failure in Mycobacterium abscessus lung diseaseKeiji Fujiwara, Koji Furuuchi, Akio Aono, et al.
Ebiomedicine|January 15, 2021
A novel DNA chromatography method to discriminate Mycobacterium abscessus subspecies and macrolide susceptibilityMitsunori Yoshida, Sotaro Sano, Jung-Yien Chien, et al.
Microbiology Spectrum|April 21, 2022
Molecular Epidemiological Characteristics of Mycobacterium abscessus Complex Derived from Non-Cystic Fibrosis Patients in Japan and TaiwanMitsunori Yoshida, Jung-Yien Chien, Kozo Morimoto, et al.
ERJ Open Research|August 12, 2025
Risk factors, molecular analysis and treatment outcomes of amikacin-resistant <i>Mycobacterium avium</i> complex pulmonary diseaseTatsuya Kodama, Akio Aono, Keiji Fujiwara, et al.
Molecular Genetics & Genomic Medicine|July 5, 2019
Recurring large deletion in DRC1 (CCDC164) identified as causing primary ciliary dyskinesia in two Asian patientsKozo Morimoto, Minako Hijikata, Maimoona A Zariwala, et al.
Pageof 20

Showing results (151-160 of 191) with videos related to

Sort By:
Pageof 20
Respiratory Medicine|September 12, 2020
Clinical significance of anti-glycopeptidolipid-core IgA antibodies in patients newly diagnosed with Mycobacterium avium complex lung diseaseShuichi Matsuda, Takanori Asakura, Kozo Morimoto, et al.
Expert Review of Respiratory Medicine|March 4, 2022
Decreased incremental shuttle walk test distance characterized by fibrocavitary lesions in non-tuberculous mycobacterial pulmonary diseaseKazuki Ono, Mitsuru Tabusadani, Kazumasa Yamane, et al.
Orphanet Journal of Rare Diseases|October 15, 2025
Genetic investigation of sinopulmonary diseases in Vietnam: seeking specific causes from non-specific symptomsPhan Thu Phuong, Nguyen Thi Le Hang, Minako Hijikata, et al.
Respiratory Medicine|May 27, 2019
Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in JapanKoji Furuuchi, Kozo Morimoto, Takashi Yoshiyama, et al.
Respiratory Investigation|January 10, 2026
Efficacy and safety of brensocatib in Japanese patients with non-cystic fibrosis bronchiectasis: Analysis of the ASPEN trialKozo Morimoto, James D Chalmers, Pierre-Régis Burgel, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 3, 2020
Clinical risk factors related to treatment failure in Mycobacterium abscessus lung diseaseKeiji Fujiwara, Koji Furuuchi, Akio Aono, et al.
Ebiomedicine|January 15, 2021
A novel DNA chromatography method to discriminate Mycobacterium abscessus subspecies and macrolide susceptibilityMitsunori Yoshida, Sotaro Sano, Jung-Yien Chien, et al.
Microbiology Spectrum|April 21, 2022
Molecular Epidemiological Characteristics of Mycobacterium abscessus Complex Derived from Non-Cystic Fibrosis Patients in Japan and TaiwanMitsunori Yoshida, Jung-Yien Chien, Kozo Morimoto, et al.
ERJ Open Research|August 12, 2025
Risk factors, molecular analysis and treatment outcomes of amikacin-resistant <i>Mycobacterium avium</i> complex pulmonary diseaseTatsuya Kodama, Akio Aono, Keiji Fujiwara, et al.
Molecular Genetics & Genomic Medicine|July 5, 2019
Recurring large deletion in DRC1 (CCDC164) identified as causing primary ciliary dyskinesia in two Asian patientsKozo Morimoto, Minako Hijikata, Maimoona A Zariwala, et al.
Pageof 20